FDA Authorizes Marketing of First Eyeglass Lenses to Slow Progression of Pediatric Myopia
Media Affairs
4,178 posts
Media Affairs
@FDAMedia
Official twitter account of FDA's Office of Media Affairs.
Request for comment form: hhs.gov/request-for-co…
- FDA Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa (vandetanib)
- FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy
- FDA Takes Action to Make a Treatment Available for Autism Symptoms
- FDA Grants Accelerated Approval to First Treatment for Barth Syndrome
- FDA Launches Real-Time Adverse Event Reporting Dashboard for Cosmetic Products bit.ly/3JYtM86
- HHS, CBP Seize $86.5 Million Worth of Illegal E-Cigarettes in Largest-Ever Operation bit.ly/45YUxBN
- FDA Issues New Guidance to Expand Non-Opioid Options for Chronic Pain, Curb Misuse
- FDA Launches Crackdown on Deceptive Drug Advertising
- FDA Approves Expanded Use of Vonvendi for von Willebrand Disease, Including for Certain Uses for Children
- FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients
- FDA Announces Real-Time Release of Complete Response Letters, Posts Previously Unpublished Batch of 89
- FDA Advances Rare Disease Drug Development with New Evidence Principles bit.ly/4lYA0C7
